Overview

A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

Status:
Recruiting

Trial end date:
2021-11-01

Target enrollment:

Participant gender:

Summary

The study is a Randomized, Open-Label, Multi-Centre, Phase 2a Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects with Severe Corona Virus Disease 2019（COVID-19）Pneumonia.

Phase:

Phase 2

Details

Lead Sponsor:

Grand Medical Pty Ltd.

Collaborator:

Trium Clinical Consulting